NCT03367936 (SMARTER) is a NA clinical trial of One-on-one Session in Overweight and Obesity, sponsored by University of Pittsburgh.

Who is sponsoring NCT03367936?

NCT03367936 is sponsored by University of Pittsburgh.

What drugs are being tested in NCT03367936?

Interventions in NCT03367936: One-on-one Session, Self-monitoring, Feedback.

What condition does NCT03367936 study?

NCT03367936 studies Overweight and Obesity.

Is NCT03367936 still recruiting?

NCT03367936 is currently completed. Last updated 13 April 2025.

Last reviewed 2025-04-13 · How we verify

NCT03367936: SMARTER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Promoting Lifestyle Change Via Tailored mHealth Feedback to Improve Health

Completed NA Last updated 13 April 2025

What this trial tests

NA trial testing One-on-one Session in Overweight and Obesity in 502 participants. Completed in 31 March 2021.

Timeline

1 August 2018

Primary endpoint
31 March 2021

31 March 2021

Quick facts

Lead sponsor	University of Pittsburgh
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	502
Start date	1 August 2018
Primary completion	31 March 2021
Estimated completion	31 March 2021
Sites	1 location across United States

Drugs / interventions tested

One-on-one Session
Self-monitoring
Feedback

Conditions studied

Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

University of Pittsburgh

Who can join

18 and older, any sex, with Overweight and Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall purpose of this randomized clinical trial is to examine the effect and efficacy of the individualized, real-time, smartphone-based feedback of diet and physical activity self-monitoring on subsequent weight-control behaviors, weight loss outcomes and sustainability of patient engagement. Participants will be randomized to one of 2 groups: (1) Self-Monitoring -similar to what many people do on their own, subjects will self-monitor diet, physical activity using Fitbit and weight using a Bluetooth-enabled scale, and (2) Self-Monitoring +Feedback-participants will self-monitor as described for the Self-Monitoring group but also will receive tailored Feedback messages. The Self-Monitoring +Feedback participants will receive up to 4 daily discrete pop-up Feedback messages on the participant's smartphone delivered at random times during waking hours and tailored to content of recorded entries in the subjects' smartphone-based diaries and a weekly summary Feedback message about the participant's weight.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

The Effect of Tailored, Daily, Smartphone Feedback to Lifestyle Self-Monitoring on Weight Loss at 12 Months: the SMARTER Randomized Clinical Trial.
Burke LE, Sereika SM, Bizhanova Z, Parmanto B, et al · · 2022 · cited 23× · PMID 35787516 · DOI 10.2196/38243
The SMARTER Trial: Design of a trial testing tailored mHealth feedback to impact self-monitoring of diet, physical activity, and weight.
Burke LE, Sereika SM, Parmanto B, Beatrice B, et al · · 2020 · cited 21× · PMID 32087342 · DOI 10.1016/j.cct.2020.105958
Effect of an mHealth weight loss intervention on Healthy Eating Index diet quality: the SMARTER randomised controlled trial.
Cheng J, Costacou T, Sereika SM, Conroy MB, et al · · 2023 · cited 11× · PMID 38713063 · DOI 10.1017/s0007114523001137
Identifying Predictors of Adherence to the Physical Activity Goal: A Secondary Analysis of the SMARTER Weight Loss Trial.
Bizhanova Z, Sereika SM, Brooks MM, Rockette-Wagner B, et al · · 2023 · cited 10× · PMID 36574734 · DOI 10.1249/mss.0000000000003114
Adherence to self-monitoring and behavioral goals is associated with improved weight loss in an mHealth randomized-controlled trial.
Burke LE, Bizhanova Z, Conroy MB, Cheng J, et al · · 2025 · cited 6× · PMID 39962997 · DOI 10.1002/oby.24234
Data Collection and Management of mHealth, Wearables, and Internet of Things in Digital Behavioral Health Interventions With the Awesome Data Acquisition Method (ADAM): Development of a Novel Informatics Architecture.
Pulantara IW, Wang Y, Burke LE, Sereika SM, et al · · 2024 · cited 5× · PMID 39113371 · DOI 10.2196/50043
Perceived and calculated diet quality improvements in a randomized mHealth weight loss trial.
Cheng J, Costacou T, Rockette-Wagner B, Sereika SM, et al · · 2024 · cited 1× · PMID 36789848 · DOI 10.1080/08964289.2023.2178374
Trajectories of Adherence to Study-Prescribed Physical Activity Goals in a mHealth Weight Loss Intervention.
Bizhanova Z, Burke LE, Brooks MM, Rockette-Wagner B, et al · · 2025 · PMID 41471593 · DOI 10.3390/s25247595

Verify or expand the search:

Other recruiting trials for Overweight and Obesity

Currently open trials in the same condition.

NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting

Other University of Pittsburgh trials

Trials by the same sponsor.

NCT05601206 — Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE · NA · not yet recruiting
NCT06652815 — Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation · not yet recruiting
NCT06474286 — Prucalopride for Cognitive Functioning in Schizophrenia · NA · not yet recruiting
NCT06488469 — Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus · NA · not yet recruiting
NCT06652802 — Effectiveness of Nurse-Conducted Brief Intervention (NCBI) Supplemented With Mobile for Preventing Alcohol Use Disorders · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03367936 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pittsburgh
Last refreshed: 13 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03367936.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing